Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range - study protocol for a randomized controlled trial. (2016)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12872-016-0405-1
PubMed Identifier: 27855643
Publication URI: http://europepmc.org/abstract/MED/27855643
Type: Journal Article/Review
Volume: 16
Parent Publication: BMC cardiovascular disorders
Issue: 1
ISSN: 1471-2261